1型糖尿病患者HDL颗粒增大且胆固醇流出能力增强:一项横断面研究
本研究纳入100例1型糖尿病患者和100例非糖尿病对照,比较HDL颗粒大小、浓度及胆固醇流出能力(CEC)。结果发现1型糖尿病患者大颗粒HDL浓度升高、平均HDL颗粒增大,总CEC及ABCA1非依赖性CEC增强,且HDL颗粒大小与总CEC独立相关,但校正后CEC在1型糖尿病中仍较高。
要点
- 1型糖尿病患者HDL颗粒增大且总CEC增强,独立于HDL颗粒大小。
- ABCA1非依赖性CEC在1型糖尿病中显著升高,而ABCA1依赖性CEC在多变量分析中差异不显著。
- HDL颗粒大小而非HDL胆固醇水平与总CEC独立相关。
核心结论
- HDL颗粒大小而非HDL胆固醇水平与总CEC独立相关。
- 1型糖尿病患者HDL颗粒增大,且校正颗粒大小后总CEC和ABCA1非依赖性CEC仍增强。
研究设计与样本
- 横断面研究,纳入100例1型糖尿病患者(37.6±1.2岁,BMI 26.9±0.5 kg/m2)和100例非糖尿病对照(37.7±1.1岁,BMI 27.1±0.5 kg/m2)。
- 采用NMR测定HDL颗粒大小和浓度,通过J774巨噬细胞向ApoB缺失血清的[3H]胆固醇流出评估总CEC、ABCA1依赖性CEC和ABCA1非依赖性CEC,并测量颈动脉内膜中层厚度(CIMT)。
主要发现
- 1型糖尿病组总HDL颗粒浓度较低(31.01±8.66 vs 34.33±8.04 μmol/l,平均差-3.32 μmol/l),但大颗粒HDL浓度较高(9.36±3.98 vs 6.99±4.05 μmol/l,平均差+2.37 μmol/l),平均HDL颗粒尺寸增大(9.82±0.57 vs 9.44±0.56 nm,平均差+0.38 nm)(所有p<0.05)。
- 1型糖尿病组总CEC较高(14.57±2.47%CEC/4 h vs 12.26±3.81%CEC/4 h,平均差+2.31%CEC/4 h)。
- ABCA1依赖性CEC(6.10±2.41 vs 5.22±2.57%CEC/4 h,平均差+0.88%CEC/4 h)和ABCA1非依赖性CEC(8.47±1.79 vs 7.05±1.76%CEC/4 h,平均差+1.42%CEC/4 h)在1型糖尿病中均较高,但ABCA1依赖性CEC的升高在多变量分析中未达统计学显著。
- CIMT在1型糖尿病中增加,但多变量分析中仅与年龄和BMI呈负相关。
临床怎么用
- 在1型糖尿病中,HDL胆固醇水平正常至偏高并不能排除HDL功能改变,评估HDL颗粒大小和CEC可能提供额外信息。
- HDL颗粒大小与总CEC独立相关,但1型糖尿病中CEC增强不完全由颗粒大小解释,提示其他机制参与。
局限性
- 横断面设计无法推断因果关系。
- 研究未明确CEC增强是否延缓动脉粥样硬化进展,需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: The prevalence of atherosclerosis is increased in type 1 diabetes despite normal-to-high HDL-cholesterol levels. The cholesterol efflux capacity (CEC) of HDL is a better predictor of cardiovascular events than static HDL-cholesterol. This cross-sectional study addressed the hypothesis that impaired HDL function contributes to enhanced CVD risk within type 1 diabetes. METHODS: We compared HDL particle size and concentration (by NMR), total CEC, ATP-binding cassette subfamily A, member 1 (ABCA1)-dependent CEC and ABCA1-independent CEC (by determining [3H]cholesterol efflux from J774-macrophages to ApoB-depleted serum), and carotid intima-media thickness (CIMT) in 100 individuals with type 1 diabetes (37.6 ± 1.2 years; BMI 26.9 ± 0.5 kg/m2) and 100 non-diabetic participants (37.7 ± 1.1 years; 27.1 ± 0.5 kg/m2). RESULTS: Compared with non-diabetic participants, total HDL particle concentration was lower (mean ± SD 31.01 ± 8.66 vs 34.33 ± 8.04 μmol/l [mean difference (MD) -3.32 μmol/l]) in participants with type 1 diabetes. However, large HDL particle concentration was greater (9.36 ± 3.98 vs 6.99 ± 4.05 μmol/l [MD +2.37 μmol/l]), resulting in increased mean HDL particle size (9.82 ± 0.57 vs 9.44 ± 0.56 nm [MD +0.38 nm]) (p < 0.05 for all). Total CEC (14.57 ± 2.47%CEC/4 h vs 12.26 ± 3.81%CEC/4 h [MD +2.31%CEC/4 h]) was greater in participants with type 1 diabetes relative to non-diabetic participants. Increased HDL particle size was independently associated with increased total CEC; however, following adjustment for this in multivariable analysis, CEC remained greater in participants with type 1 diabetes. Both components of CEC, ABCA1-dependent (6.10 ± 2.41%CEC/4 h vs 5.22 ± 2.57%CEC/4 h [MD +0.88%CEC/4 h]) and ABCA1-independent (8.47 ± 1.79% CEC/4 h vs 7.05 ± 1.76% CEC/4 h [MD +1.42% CEC/4 h]) CEC, were greater in type 1 diabetes but the increase in ABCA1-dependent CEC was less marked and not statistically significant in multivariable analysis. CIMT was increased in participants with type 1 diabetes but in multivariable analysis it was only associated negatively with age and BMI. CONCLUSIONS/INTERPRETATION: HDL particle size but not HDL-cholesterol level is independently associated with enhanced total CEC. HDL particle size is greater in individuals with type 1 diabetes but even after adjusting for this, total and ABCA1-independent CEC are enhanced in type 1 diabetes. Further studies are needed to understand the mechanisms underlying these effects, and whether they help attenuate progression of atherosclerosis in this high-risk group. Graphical abstract.
引用
- Ahmed MO, Byrne RE, Pazderska A, et al. HDL particle size is increased and HDL-cholesterol efflux is enhanced in type 1 diabetes: a cross-sectional study. Diabetologia. 2020. PMID: 33169205. doi:10.1007/s00125-020-05320-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。